NEW YORK (GenomeWeb) – Australian molecular diagnostics firm Genetic Technologies today announced it has regained compliance to continue listing its shares on the Nasdaq. 

Genetic Technologies received a warning letter from Nasdaq in November 2014 telling the firm it did not meet a listing requirement of at least $2.5 million in stockholder equity. The company said today that it had net assets of about A$21 million (about US$16.5 million) as of March 31, allowing it continue listing its stock on the Nasdaq.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.